251 related articles for article (PubMed ID: 10890724)
21. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats.
Marques MR; da Silva MA; Manzi FR; Cesar-Neto JB; Nociti FH; Barros SP
Arch Oral Biol; 2005 Apr; 50(4):421-9. PubMed ID: 15748695
[TBL] [Abstract][Full Text] [Related]
22. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
23. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy.
Boyce RW; Wronski TJ; Ebert DC; Stevens ML; Paddock CL; Youngs TA; Gundersen HJ
Bone; 1995 Feb; 16(2):209-13. PubMed ID: 7756049
[TBL] [Abstract][Full Text] [Related]
24. Anti-resorptive agents reduce the size of resorption cavities: a three-dimensional dynamic bone histomorphometry study.
Matheny JB; Slyfield CR; Tkachenko EV; Lin I; Ehlert KM; Tomlinson RE; Wilson DL; Hernandez CJ
Bone; 2013 Nov; 57(1):277-83. PubMed ID: 23988275
[TBL] [Abstract][Full Text] [Related]
25. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
26. Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone.
Callaci JJ; Juknelis D; Patwardhan A; Wezeman FH
Alcohol Clin Exp Res; 2006 Apr; 30(4):665-72. PubMed ID: 16573585
[TBL] [Abstract][Full Text] [Related]
27. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
Cheng PT; Chan C; Müller K
J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
[TBL] [Abstract][Full Text] [Related]
28. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
[TBL] [Abstract][Full Text] [Related]
29. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
30. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
31. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis.
Ibbotson KJ; Orcutt CM; D'Souza SM; Paddock CL; Arthur JA; Jankowsky ML; Boyce RW
J Bone Miner Res; 1992 Apr; 7(4):425-32. PubMed ID: 1609630
[TBL] [Abstract][Full Text] [Related]
32. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
Mosekilde L; Danielsen CC; Gasser J
Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
[TBL] [Abstract][Full Text] [Related]
33. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.
Shen V; Dempster DW; Birchman R; Xu R; Lindsay R
J Clin Invest; 1993 Jun; 91(6):2479-87. PubMed ID: 8514860
[TBL] [Abstract][Full Text] [Related]
34. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
[TBL] [Abstract][Full Text] [Related]
35. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
Samnegård E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
[TBL] [Abstract][Full Text] [Related]
36. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.
Li M; Shen Y; Burton KW; DeLuca PP; Mehta RC; Baumann BD; Wronski TJ
Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397
[TBL] [Abstract][Full Text] [Related]
38. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
39. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC; Kalu DN
J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
[TBL] [Abstract][Full Text] [Related]
40. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
